Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sartipy

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Trends in Cardiovascular Medicine|November 30, 2000
Modification of plasma lipoproteins by group IIA phospholipase A(2): possible implications for atherogenesisP Sartipy, E Hurt-Camejo
Current Opinion in Lipidology|October 26, 2000
Phospholipase A2 and small, dense low-density lipoproteinE Hurt-Camejo, G Camejo, P Sartipy
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 1998
Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixesP Sartipy, G Bondjers, E Hurt-Camejo
The Journal of Biological Chemistry|August 28, 1999
Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycansP Sartipy, G Camejo, L Svensson, et al.
Circulation Research|April 4, 2000
Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesionsP Sartipy, B Johansen, K Gâsvik, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 14, 1999
Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrixU Lundstam, E Hurt-Camejo, G Olsson, et al.
The Journal of Biological Chemistry|June 26, 1999
CD44, a cell surface chondroitin sulfate proteoglycan, mediates binding of interferon-gamma and some of its biological effects on human vascular smooth muscle cellsE Hurt-Camejo, B Rosengren, P Sartipy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 1, 1995
Interferon gamma binds to extracellular matrix chondroitin-sulfate proteoglycans, thus enhancing its cellular responseE H Camejo, B Rosengren, G Camejo, et al.
The Journal of Biological Chemistry|October 18, 1996
Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activityP Sartipy, B Johansen, G Camejo, et al.
Biochimica Et Biophysica Acta|April 13, 2000
Endogenously produced glycosaminoglycans affecting the release of lipoprotein lipase from macrophages and the interaction with lipoproteinsR Zimmermann, P Sartipy, R Winkler, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Trends in Cardiovascular Medicine|November 30, 2000
Modification of plasma lipoproteins by group IIA phospholipase A(2): possible implications for atherogenesisP Sartipy, E Hurt-Camejo
Current Opinion in Lipidology|October 26, 2000
Phospholipase A2 and small, dense low-density lipoproteinE Hurt-Camejo, G Camejo, P Sartipy
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 1998
Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixesP Sartipy, G Bondjers, E Hurt-Camejo
The Journal of Biological Chemistry|August 28, 1999
Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycansP Sartipy, G Camejo, L Svensson, et al.
Circulation Research|April 4, 2000
Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesionsP Sartipy, B Johansen, K Gâsvik, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 14, 1999
Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrixU Lundstam, E Hurt-Camejo, G Olsson, et al.
The Journal of Biological Chemistry|June 26, 1999
CD44, a cell surface chondroitin sulfate proteoglycan, mediates binding of interferon-gamma and some of its biological effects on human vascular smooth muscle cellsE Hurt-Camejo, B Rosengren, P Sartipy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 1, 1995
Interferon gamma binds to extracellular matrix chondroitin-sulfate proteoglycans, thus enhancing its cellular responseE H Camejo, B Rosengren, G Camejo, et al.
The Journal of Biological Chemistry|October 18, 1996
Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activityP Sartipy, B Johansen, G Camejo, et al.
Biochimica Et Biophysica Acta|April 13, 2000
Endogenously produced glycosaminoglycans affecting the release of lipoprotein lipase from macrophages and the interaction with lipoproteinsR Zimmermann, P Sartipy, R Winkler, et al.
Pageof 2